Majority of blood banks in city are cheating patients
By Jyoti Shelar, Mumbai Mirror | Mar 31, 2015, 12.00 AM IST
An FDA probe against 19 blood banks, including those attached to leading hospitals, has revealed that just three of them - Hinduja, Lilavati, and BD Petit Parsee Hospital - were charging patients correctly.
The Food and Drug Administration (FDA) probe into 19 blood banks in the city has found that majority of them have been charging more than the rates prescribed by the state government.
According to the FDA's joint commissioner, Sanjay Patil, only three blood banks- attached to Hinduja Hospital, Lilavati Hospital and BD Petit Parsee General Hospital - were found to be accurately charging patients. "The remaining 16 blood banks were over charging anywhere between Rs. 50 and Rs. 500," Patil said.
A government resolution dated June 2014 has set Rs. 1,450 as the price for one unit of whole blood, Rs. 1,450 for packed red cells, Rs. 400 for fresh frozen plasma, Rs. 400 for one unit of platelets, and Rs. 250 for cryo precipitate.
In November last year, the FDA officials inspected 309 blood banks across the state, of which 72 were found to have discrepancies in charging process. Out of the 72 blood banks, 19 were from Mumbai.
"Detailed inquiry was conducted in all these 72 blood banks including 19 in Mumbai, and merely three were given clean chit," Patil said, adding that in Mumbai, blood banks of leading hospitals such as Jaslok, Breach Candy, Cumballa Hill, the Bombay Hospital, Asian Heart Institute, Prince Aly Khan, Kokilaben Dhirubhai Ambani, SevenHills Hospital, Raheja and Fortis were found to be overcharging patients. Among the independent blood banks, the Borivali Blood Bank, Suburban Hightech (Malad), Manas Serological (Jogeshwari), West Coast (Mahim), SR Mehta Cardiac Instate (Sion) and Ashirwad (Dadar) were found to be over charging patients.
While the FDA had already issued show cause notices to the blood banks, the names have also been sent to the State Blood Transfusion Council (SBTC) for action. "After we issued notices, these blood banks have corrected their rates.
However, action has to be taken as they were found over charging during the inquiry," Patil said, adding that there is no act or clause under which FDA can take action. "Since SBTC has the powers, they will have to initiate action," he said.
View Pdf
View Doc